Funeral procession leads to chaos in BC Road; stones pelted at shops, vehicles

Mangaluru, May 13: Union Minister and former Karnataka chief minister D V Sadananda Gowda today assured that he will exert pressure on the authorities concerned to operate more repatriate flights to bring back Kannadigas from Saudi Arabia to Karnataka. 

Speaking in a video conference organised by coastaldigest.com with Kannadiga delegates in Saudi Arabia, Mr Gowda said: “Today itself I will contact the external affairs ministry and Director General of Civil Aviation (DGCA) to convince them the need to add operate flights to bring back stranded Kannaidgas from the Kingdom.

After paying heed to the advices, requests and concerns of Kannadiga delegates that participated in the video conference, Mr Gowda said: “Two things need to be done. First thing is number of flights from Saudi Arabia to Karnataka should be increased. Second thing is to ensure that most of these flights land in the Mangaluru Airport as most of the Kannadiga expats in Saudi Arabia are from the coastal region.

“There should be at least two to three flights from Saudi Arabia to Karnataka (Bengaluru Airport or Mangaluru Airport) every week. That is my intention,” he added.

Tirupati, Jul 5: The Karnataka government will soon build a massive pilgrim amenities complex and marriage hall at Tirumala, the hill abode of Lord Venkateswara, at an estimated cost of Rs 200 crore, a temple official said here on Saturday.

The state would soon submit a blueprint for the construction of the Rs 200 crore mega complexes to the Tirumala Tirupati Devasthanams (TTD) that governs the hill shrine, the official said.

Consequently, based on the designs, TTD would construct the complexes with the given fund and after completion, they would be handed over to the Karnataka government, he said.

Karnataka Chief Minister BS Yediyurappa would lay the foundation stone for the mammoth complexes on the hills some time next month, he said.

Andhra Pradesh Chief Minister Y S Jagan Mohan Reddy is likely to take part in the programme, he added.

Bengaluru, Mar 27: Oncologist Dr. Vishal Rao, HCG Hospital Bengaluru on Friday said that human body cells release interferon chemical to kill viruses but it cannot be released by cells in the case of COVID-19 cases, leading to weak immune system. However, a therapy of specific concoction could be useful in treating COVID-19 patients.

"We got hold of some preprint suggesting that interferon is effective in COVID19," said Rao.

Speaking to news agency, he continued saying "When we withdraw blood for regular check-ups, we get buffy coat which can be used to take out cells and form interferon. These two chemicals and some other cytokines, in a specific concoction, could be potentially very useful in treating COVID-19 patients."

Rao said that they have built a concoction of cytokines which can be injected to reactivate immune system in COVID-19 patients.

"We are in a very initial stage and hope to be ready with its first set by this weekend. We have applied to the governement for an expedited review. We have also presented this before the state government" said Rao.

"We have a team of infection specialist, ICU team and other...all of us have worked together to build something that we believe. We want to serve the society at this hour of need," he added.

Dr Rao clarified that this is not a vaccine and this particular interferon therapy does not help to prevent the infection of COVID-19. However, this is focused and targeted towards COVID-19 positive patients or those who have just incubated the virus.

"We believe that in early stages as well as the patients who have just incubated, this particular therapy of interferon gama and other concoction of cytokines could be an effective method. In the late stages we are looking at specific dosage of the cells which are our own body cells which can actually be affective and could also be of use for the ventilator patients," he added.

Meanwhile, Dr Gururaj, Immunologist and Scientist told ANI that they are trying to cover two aspects, one is the early stage patients where they are trying to improve their immune systems.

"As Dr Vishal said, we are trying to see whether we can use the cytokines from our own immune cells which is a natural process but it is hampered in infected patients," said Dr Gururaj.

"In the last phase we are using cells which are used from the bone marrow of the patient or donors. We can use those cells to reduce the inflation and so called cytokines release syndrome which is basically the inflammatory response of the body," he added.